CN1748499A - lung preservation solution - Google Patents
lung preservation solution Download PDFInfo
- Publication number
- CN1748499A CN1748499A CN 200510104232 CN200510104232A CN1748499A CN 1748499 A CN1748499 A CN 1748499A CN 200510104232 CN200510104232 CN 200510104232 CN 200510104232 A CN200510104232 A CN 200510104232A CN 1748499 A CN1748499 A CN 1748499A
- Authority
- CN
- China
- Prior art keywords
- organ
- dextran
- osmotic pressure
- magnesium sulfate
- ulinastatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
本发明为一种肺保存液,属于一种鲜活器官保存物质。The invention relates to a lung preservation solution, which belongs to a fresh and living organ preservation substance.
目前进行肺保存的物质一般有细胞内液型保存液和细胞外液型保存液,前者以Euro-collins液(EC液)和University of wisconsin(U液)为主,后者以低钾右旋糖酐液为主。前者对肺的保存效果较差,一般为4~6小时,而且,这两种保存液均为高钾溶液,对肺的损害较大。后者也未见保存时间超过6小时的报道。At present, the materials for lung preservation generally include intracellular liquid type preservation liquid and extracellular liquid type preservation liquid. The former is mainly composed of Euro-collins liquid (EC liquid) and University of wisconsin (U liquid), while the latter is mainly composed of low potassium dextran liquid. Mainly. The preservation effect of the former on the lungs is poor, generally 4 to 6 hours, and both of these two preservation solutions are high-potassium solutions, which will cause greater damage to the lungs. The latter also has no reports of preservation time exceeding 6 hours.
本发明的目的在于,公开一种保存效果好的肺保存液。The purpose of the present invention is to disclose a lung preservation solution with good preservation effect.
本发明是由氯化钠、氯化钾、硫酸镁、碳酸氢钠、右旋糖酐-40、渗透压与水混合而成,其中,每升中各成份的含量为:氯化钠:0.6~1.0g,氯化钾0.02~0.04g,硫酸镁7.0~7.6g,碳酸氢钠0.6~1.0g,右旋糖酐-40:40~60g,乌司他丁:25,000~50,000u/kg;其渗透压的数值范围为300~350mosm/l。本发明中含有乌司他丁,它能够起到抑制组织细胞代谢的作用,使被保存的器官在10℃左右的保存温度下降低代谢酶活性,减少分解代谢,延长组织细胞生命,达到预期的保存器官功能的目的。它以现代器官保存技术理论为基础,结合抗氧化、特殊的渗透作用、细胞交换促进机制,将乌司他丁运用于器官保存方面,用于减少器官移植中的缺血再灌注损伤、延长器官移植的保存时间,减少保存期的损伤,降低移植后原发性无功能的发生率,减少保存损伤而导致的排斥反应,从而从总体上改善器官移植的近期和远期效果。它可以使实验动物离体移植器官的保存时间延长1倍。在具体生产时,组成本发明的各成份可采用以下具体数据:每升中各成份的含量为:氯化钠:0.8~0.9g,氯化钾0.02~0.04g,硫酸镁7.2~7.5g,碳酸氢钠0.8~0.9g,右旋糖酐-40:45~50g,乌司他丁30,000~40,000u/kg,渗透压的数值范围为310~330mosm/l。The present invention is formed by mixing sodium chloride, potassium chloride, magnesium sulfate, sodium bicarbonate, dextran-40, osmotic pressure and water, wherein, the content of each component in each liter is: sodium chloride: 0.6~1.0g , potassium chloride 0.02~0.04g, magnesium sulfate 7.0~7.6g, sodium bicarbonate 0.6~1.0g, dextran-40: 40~60g, ulinastatin: 25,000~50,000u/kg; the numerical range of its osmotic pressure 300-350 mosm/l. The present invention contains ulinastatin, which can inhibit the metabolism of tissue cells, reduce the activity of metabolic enzymes in the preserved organs at a storage temperature of about 10°C, reduce catabolism, prolong the life of tissue cells, and achieve the desired effect. The purpose of preserving organ function. It is based on the theory of modern organ preservation technology, combined with anti-oxidation, special osmotic effect, and cell exchange promotion mechanism. The storage time of transplantation can reduce the damage during the storage period, reduce the incidence of primary non-function after transplantation, and reduce the rejection caused by storage damage, so as to improve the short-term and long-term effects of organ transplantation as a whole. It can double the preservation time of the isolated transplanted organs of experimental animals. When concrete production, each composition of forming the present invention can adopt following specific data: the content of each composition in every liter is: sodium chloride: 0.8~0.9g, potassium chloride 0.02~0.04g, magnesium sulfate 7.2~7.5g, Sodium bicarbonate 0.8-0.9g, dextran-40: 45-50g, ulinastatin 30,000-40,000u/kg, osmotic pressure ranges from 310-330mosm/l.
具体实施方式Detailed ways
各实施例中每升溶液中各成份的含量如下:
上述各实施例中的成份在常温下混合制成本发明。按上述成份制成的本发明其渗透压参数不在要求范围之内时,按公知方法对其进行调整。The ingredients in the above-mentioned embodiments are mixed at normal temperature to make the present invention. When the osmotic pressure parameter of the present invention made by the above-mentioned ingredients is not within the required range, it can be adjusted by known methods.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101042322A CN1307871C (en) | 2005-10-11 | 2005-10-11 | Lung preserving liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101042322A CN1307871C (en) | 2005-10-11 | 2005-10-11 | Lung preserving liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1748499A true CN1748499A (en) | 2006-03-22 |
| CN1307871C CN1307871C (en) | 2007-04-04 |
Family
ID=36604302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101042322A Expired - Fee Related CN1307871C (en) | 2005-10-11 | 2005-10-11 | Lung preserving liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1307871C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101803594A (en) * | 2009-02-14 | 2010-08-18 | 青岛华仁药业股份有限公司 | Organ preservation solution and preparation method thereof |
| CN103461322A (en) * | 2012-06-07 | 2013-12-25 | 臻景生物技术(上海)有限公司 | Preservation solution for freezing resuscitated cells |
| CN106342788A (en) * | 2011-04-14 | 2017-01-25 | 特兰斯迈迪茨公司 | Organ care solution for ex-vivo machine perfusion of donor lungs |
| CN112273373A (en) * | 2020-10-29 | 2021-01-29 | 无锡市人民医院 | Isolated lung mechanical perfusion liquid and preparation method and application thereof |
| CN113498777A (en) * | 2021-07-26 | 2021-10-15 | 公卫复医(上海)生物科技有限公司 | Emulsion type organ preservation solution and preparation method thereof |
-
2005
- 2005-10-11 CN CNB2005101042322A patent/CN1307871C/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101803594A (en) * | 2009-02-14 | 2010-08-18 | 青岛华仁药业股份有限公司 | Organ preservation solution and preparation method thereof |
| CN101803594B (en) * | 2009-02-14 | 2013-07-31 | 青岛华仁药业股份有限公司 | Organ preservation solution and preparation method thereof |
| CN106342788A (en) * | 2011-04-14 | 2017-01-25 | 特兰斯迈迪茨公司 | Organ care solution for ex-vivo machine perfusion of donor lungs |
| CN106342788B (en) * | 2011-04-14 | 2020-03-17 | 特兰斯迈迪茨公司 | Organ care solution for ex vivo machine perfusion of donor lungs |
| CN103461322A (en) * | 2012-06-07 | 2013-12-25 | 臻景生物技术(上海)有限公司 | Preservation solution for freezing resuscitated cells |
| CN103461322B (en) * | 2012-06-07 | 2016-08-03 | 西比曼生物科技(上海)有限公司 | The preservation liquid of the cell after cryopreservation resuscitation |
| CN112273373A (en) * | 2020-10-29 | 2021-01-29 | 无锡市人民医院 | Isolated lung mechanical perfusion liquid and preparation method and application thereof |
| CN112273373B (en) * | 2020-10-29 | 2022-06-07 | 无锡市人民医院 | Isolated lung mechanical perfusion liquid and preparation method and application thereof |
| CN113498777A (en) * | 2021-07-26 | 2021-10-15 | 公卫复医(上海)生物科技有限公司 | Emulsion type organ preservation solution and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1307871C (en) | 2007-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8017311B2 (en) | Method for treatment of cellular materials with sugars prior to preservation | |
| CN101228898A (en) | Composite preservative for prolonging storage time of loquat fruit and preparation method thereof | |
| JP2010539107A5 (en) | ||
| CN104996396A (en) | In-vitro liver perfusion preservation solution | |
| CN102630829B (en) | Athetis lepigone larva feed and preparation method thereof | |
| CN1307871C (en) | Lung preserving liquid | |
| CN106538510A (en) | The application of lycopene and sesamol compatibility in domestic animal semen cryopreservation agent | |
| CN108424318A (en) | A kind of raising crop resists ammonium gluconate preparation of salt stress ability and the preparation method and application thereof | |
| CN102144665A (en) | A silver-loaded nano-TiO2 antibacterial and fresh-keeping method for Nanfeng Tangerine | |
| CN103734280A (en) | Fructus momordicae preservative and application method thereof | |
| CN103719264A (en) | Mango water retention sterilization filming liquid and preparation method thereof | |
| CN106172719A (en) | A kind of snap bean antistaling agent | |
| CN110754442A (en) | Silkworm embryo low-temperature protection and seed-delay technology | |
| CN108419723A (en) | A kind of carbon dioxide narcosis method of seawater grouper | |
| CN102626112B (en) | A kind of composite anti-transpiration agent and its preparation method and application | |
| JPH10229708A (en) | Method for accelerating germination | |
| CN109122663A (en) | A kind of freeze-drying refrigeration for the very wide water flea resting egg in the long-term preservation Pacific Ocean | |
| CN110178834A (en) | A kind of grouper sperm cryopreservation method | |
| CN107801764A (en) | A kind of preservation method of program cooling krill | |
| CN115918533A (en) | A method for ultra-low temperature preservation of Guimu No. 1 Elephant Grass droplet vitrification method | |
| Třeška et al. | Can ischemia-reperfusion syndrome in transplanted kidneys procured from non–heart-beating donors be influenced by adding selenium into the reperfusion solution? an experimental study | |
| Gudleifsson | Metabolic and cellular impact of ice encasement on herbage plants | |
| CN106342786A (en) | Diluent for in-vitro low temperature preservation of boar semen and preparation method thereof | |
| CN105248610A (en) | Egg fresh-keeping agent | |
| Sudomo et al. | Water, energy, and food nexus with agroforestry system for sustainable development goals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: MEDICAL COLLEGE OF SHANTOU UNIVERSITY Free format text: FORMER NAME OR ADDRESS: GUO LEI |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |